A physician-owned oncology practice is looking for an LLC consulting firm to audit their current billing workflows, identify revenue leakage, and provide staff training. They want specific deliverables like denial rate analysis, coding accuracy reviews, and payer contract renegotiation support.
The deliverables your practice listed are exactly the right ones to anchor the engagement on, so vet firms on whether they’ll commit to them in writing rather than treating them as discovery-phase nice-to-haves.
For an oncology practice specifically, the revenue leakage usually hides in a few predictable places: J-code and drug billing units (especially with NDC reporting and wastage modifiers like JW/JZ), prior auth lapses on high-cost infusions, underpayments on chemo administration codes, and timely-filing denials that never get worked. A good audit should quantify each of those, not just hand you a generic denial rate.
A few questions worth asking any firm before signing:
- Do they staff certified oncology coders (CPC plus oncology-specific experience), or generalists? Oncology coding depth matters here.
- Will the denial analysis break down by payer and denial reason code (CARC/RARC), or is it one blended number?
- On payer contract renegotiation, do they actually have benchmarking data on your top payers, or are they just reviewing your existing contracts?
- Is staff training a one-time session or ongoing, and do they leave you with documentation?
On firms: Coronis Health has a dedicated oncology line and does the contract/underpayment work well.
Transcure’s oncology billing team handles the audit-plus-coding-accuracy side and tends to be a fit for physician-owned groups that want hands-on workflow cleanup rather than just a report. If you’re a larger group, the bigger RCM shops like R1 will pitch you too, though they’re often built more for health systems than independent practices.
One thing to flag: be cautious of anyone who leads with a percentage-of-collections model before they’ve audited you. You want the audit findings to set the scope, not the pricing model.
Want me to adjust the anchor placement or tighten the Transcure framing to match the forum’s self-promo norms? Some communities flag commercial links hard, so I can soften it further if needed.
Oncology revenue cycle performance lives or dies on coding precision and drug reimbursement, which is exactly where a specialized firm earns its fee. General billers treat oncology like any other specialty, and that assumption is what causes the leakage.
A focused oncology billing and consulting firm improves performance in a few concrete ways.
First, coding accuracy on the parts that actually move money. The chemotherapy administration hierarchy (96401 through 96417), J-code drug units, and NDC reporting all carry denial risk when handled by generalists. Accurate first-pass coding protects both the administration fee and the drug margin.
Second, prior authorization discipline. High-cost biologics and infusions require authorization before treatment. A firm that tracks payer-specific rules prevents the write-offs that follow a missed or expired auth.
Third, denial and appeals management built around oncology medical-necessity edits, LCD and NCD policies, and bundling rules that shift every quarter.
Fourth, buy-and-bill and ASP reimbursement oversight, so the practice is not absorbing the spread on expensive drugs.
As a reference point, Oncology Billing & Consulting Firm, LLC has served hematology-oncology practices since 2003 and reports net collections in the 95 to 100 percent range, supported by oncology-specific application tools. Whether or not a given firm hits those numbers, that is the right benchmark to hold any partner to.
The practical test is simple. Ask any consulting firm for their net collection rate, first-pass clean claim rate, and average days in AR, segmented for oncology specifically. Then ask how they handle a denied biologic claim from your top payer. The answer reveals whether they understand oncology or just bill it.
For a practice weighing in-house versus outsourced, the consulting layer often matters more than the billing itself, since it fixes root causes rather than reworking claims.